Medical Research
(H11)
IRS Verified
DX Registered
990 on File
CATTLEMEN FOR CANCER RESEARCH
Financial strength (30%)
68/100
Reliability (20%)
40/100
Effectiveness (25%)
63/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$142K
Total Revenue
$28K
Total Expenses
$262K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.9%
Fundraising Efficiency
18.0%
Operating Reserve
113.17x
Liability-to-Asset
N/A
Revenue Diversification
14.5%
Compared with Peers
FY 2024
Compared with 782 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
98.9% | 78.0% |
P10P90
|
Top quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
18.0% | 42.5% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
113.2 mo | 38.9 mo |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
14.5% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
82.2% | -0.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
736.4% | -6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
80.5% | 15.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $142K | $28K | $262K | 98.9% | — |
| 2023 | $78K | $3K | $148K | 91.0% | — |
| 2022 | $76K | $3K | $73K | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.